Home › Kidney Diseases › NCT06693661
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
Improving Access to Nephrology Treatment and Care Among Patients at Greatest Risk for Kidney Failure
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Identifies as African American or Black * Two estimated glomerular filtration rates (eGFRs) \< 29 separated by at least 90 days but within the past 2 years, or a Kidney Failure Risk Equation (KFRE) score of 10% or greater likelihood of kidney failure within the next 2 years * Had an encounter at Emory Healthcare through an ambulatory visit or inpatient stay (i.e., ER or hospital visit within the previous 2 months * Stated willingness to comply with all study procedures and availability for the duration of the study Exclusion Criteria: * Currently on dialysis * currently receiving hospice care or other types of conservative management for terminal illness * Currently on waitlist, or referred for/or completed a transplant evaluation visit within the past 2 years * Kidney or another solid organ transplant * Active cancer treatment * Non-English speaking * Participating in another treatment or intervention study at the time of enrollment * Currently pregnant or planning to become pregnant at the time of recruitment
About the study
Through the use of community-engaged processes, this project seeks to develop and implement clinical decision support (CDS) and a kidney health coaching (KHC) intervention. The CDS seeks to streamline workflows to effectively screen, identify, and link to care for those patients with advanced chronic kidney disease (CKD).
The overall project goals are to 1.) Design and conduct community-engaged clinical trials to test new interventions that dismantle the systemic factors that contribute to kidney health disparities. 2.) Foster research collaborations between investigators, people living with kidney disease, community-based organizations, and other key stakeholders.
Researchers aim to assess whether the KHC intervention is effective at delaying the transition to kidney replacement therapy (KRT) and central venous catheter use or death.
What is being tested
- Kidney Health Coaching (other)
- Usual Care (other)
Sponsor: Emory University · Participants: 600 · Started: Mar 10, 2026
Contact the study team
- Kimberly R Jacob Arriola, PhD, MPH · Phone: 404-727-2600
Official record on ClinicalTrials.gov — NCT06693661
Locations in the U.S.
| Georgia | Emory Healthcare System, Atlanta Emory University Hospital Midtown, Atlanta |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.